Abstract
The BIOX® process for the treatment of refractory gold concentrates has been in commercial operation for 35 years following the commissioning of the first commercial installation at the Fairview Gold Mine in 1986. The process has been proven to operate successfully over a wide range of concentrate feed grades and mineralogies, climatic conditions, and site altitudes.
In 2020, Metso Outotec launched its novel two-stage MesoTHERM BIOX technology, a hybrid biooxidation process specifically targeting certain oxidised refractory samples which typically consume high levels of cyanide during the leaching process. Traditionally, cyanide consumption represents a significant operating cost in most gold leach circuits with conventional BIOX plants included. MesoTHERM technology application treating refractory gold samples has seen cyanide consumption reduced by up to 50% compared to mesophile BIOX products.
In 2010, Metso Outotec introduced the ASTER™ process for improved water balances in commercial BIOX applications in both arid and tropical regions. Previously, a common challenge for BIOX plants was the inability to recycle thiocyanate-containing water due to the low tolerance of the organisms. ASTER, a biological thiocyanate destruction process, produces a non-toxic solution for reuse in BIOX. Four commercial ASTER plants are in operation with the fifth ASTER plant under construction in Zimbabwe.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dash RR, Gaur A, Balomajumder C (2009) Cyanide in industrial wastewaters and its removal: a review on biotreatment. J Hazard Mater 163:1–11. https://doi.org/10.1016/j.jhazmat.2008.06.051
Gokulakrishnan S, Gummani SN (2006) Kinetics of cell growth and caffeine utilization by Pseudomonas sp. GSC 1182. Process Biochem 41:1417–1421. https://doi.org/10.1016/j.procbio.2005.12.018
Legodi W, Kweto B, Sandenbergh RF, Van Buuren C (2020) Strategies for reducing cyanide consumption during cyanidation of BIOX treated gold ores, Cape Town. In: International mineral processing congress, Cape Town, pp 4–5
Luthy RG, Bruce SG (1979) Kinetics of reaction of cyanide and reduced sulfur species in aqueous solution. Environ Sci Technol 13:1481–1487. https://doi.org/10.1021/jm00001a005
Patil YB, Paknikar KM (1999) Removal and recovery of metal cyanides using a combination of biosorption and biodegradation processes. Biotechnol Lett 21:913–919. https://doi.org/10.1023/A:1005550707798
Sand W, Gehrke T, Hallman R, Schippers A (1995) Sulfur chemistry, biofilm, and the (in) direct attack mechanism – a critical evaluation of bacterial leaching. Appl Microb Biotechnol 43:961–966. https://doi.org/10.1007/BF00166909
van Buuren C, Makhotla N, Olivier JW (2011) The ASTER process: technology development through to piloting, demonstration and commercialization. In: Proceedings of the ALTA 2011 Nickel-Cobalt-Copper, Uranium and Gold Conference, Perth 23–28 May 2011
van Hille RP (2011) Critical review of the ASTER technology for the treatment of cyanide and thiocyanate containing process water, Metso Outotec Internal Report
van Niekerk JA, Olivier JW Savelle M (2017) Commissioning of the BIOX and ASTER™ processes at the Runruno gold project, proceedings of the 7th world gold conference, Paper 9385, p 7–8
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
van Niekerk, J.A., van Buuren, C.B., Olivier, J.W. (2023). Bioprocessing of Refractory Gold Ores: The BIOX, MesoTHERM, and ASTER Processes. In: Johnson, D.B., Bryan, C.G., Schlömann, M., Roberto, F.F. (eds) Biomining Technologies. Springer, Cham. https://doi.org/10.1007/978-3-031-05382-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-031-05382-5_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-05381-8
Online ISBN: 978-3-031-05382-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)